Effects of different density gradient separation techniques on neutrophil function.
Investigation of the pathogenesis of inflammatory diseases has involved assessment of polymorphonuclear leukocyte (PMN) activity and a variety of techniques for separating PMNs from whole blood have been described. In this study the effects of Percoll gradient, Ficoll-Hypaque/Dextran sedimentation (FH/DS) and Mono-Poly Resolving Medium (M-PRM) on activation and function of PMNs were compared. All three separation techniques gave similar cell yield and purity. The mean (+/- SEM) percentage of cells demonstrating pseudopodia formation for Percoll, FH/DS and M-PRM were 39 +/- 9, 57 +/- 6 and 63 +/- 5, respectively, while superoxide release from resting cells was 1.9 +/- 0.9, 7.2 +/- 3.5 and 11 +/- 4.8 pmols per 10(6) cells min-1, respectively, indicating that activation of cells during separation may be less with Percoll compared to the other methods. The functional capacity of the cells to respond to a stimulus was similar for all methods as indicated by similar EC50 values for chemotaxis to zymosan-activated serum and similar superoxide production induced by tetradecanoyl phorbol acetate. All three separation techniques produce functionally active PMNs of high purity but the use of Percoll gradients may be preferable when a quick method of separation which causes minimum pre-activation of PMNs is required.
Venaille
T J
TJ
Department of Medicine, University of Western Australia, Nedlands.
Misso
N L
NL
Phillips
M J
MJ
Robinson
B W
BW
Thompson
P J
PJ
D002469:Cell Separation / Q000379:methods*; D002499:Centrifugation, Density Gradient; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003102:Colloids; D003911:Dextrans; D005362:Ficoll; D006801:Humans; D007958:Leukocyte Count; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D016877:Oxidants / Q000378:metabolism; D011205:Povidone; D011554:Pseudopodia; D012822:Silicon Dioxide; D013268:Stimulation, Chemical; D013481:Superoxides / Q000097:blood; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D003102:Colloids; D003911:Dextrans; D016877:Oxidants; D013481:Superoxides; D005362:Ficoll; C016039:Percoll; D012822:Silicon Dioxide; D011205:Povidone; D013755:Tetradecanoylphorbol Acetate